Evoke Pharma Stock (NASDAQ:EVOK)
Previous Close
$4.57
52W Range
$3.54 - $17.40
50D Avg
$5.11
200D Avg
$6.03
Market Cap
$6.49M
Avg Vol (3M)
$435.83K
Beta
0.35
Div Yield
-
EVOK Company Profile
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
EVOK Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AKAN | Akanda Corp. |
| BFRI | Biofrontera Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| GHSI | Guardion Health Sciences, Inc. |
| RGC | Regencell Bioscience Holdings Limited |
| IXHL | Incannex Healthcare Limited |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| DERM | Journey Medical Corporation |
| PTPI | Petros Pharmaceuticals, Inc. |
| ACRX | Talphera, Inc. |
| CPIX | Cumberland Pharmaceuticals Inc. |
| PROC | Procaps Group S.A. |
| JUPW | Safety Shot Inc |
| ADMP | Adamis Pharmaceuticals Corporation |
| PRFX | PainReform Ltd. |
| AGRX | Agile Therapeutics, Inc. |
| AVDL | Avadel Pharmaceuticals plc |
| EGRX | Eagle Pharmaceuticals, Inc. |